Simcere Pharma (02096) announced interim results: 截至2026年6月30日止六個月中期業績公告, net profit attributable to owners RMB8.3bn Title: 截至2026年6月30日止六個月中期業績公告 Revenue: RMB45.8bn Net profit: RMB8.3bn Profit attributable to owners: RMB8.3bn
